Share on

North America Contraceptives Market Research Report – Segmented By Drug Type, Medical Devices, End-Users, Country (the United States, Canada and Rest of North America) - Industry Analysis, Size, Share, Growth, Trends, Forecast | 2022 to 2027

Published: January, 2022
ID: 1155
Pages: 136
Formats: report pdf report excel report power bi report ppt

North America Contraceptives Market Size (2022 to 2027)

As per our report, the Contraceptives Market size in North America was worth USD 7.80 billion in 2022 and estimated to reach USD 10.64 billion by the end of 2027, registering a CAGR of 6.40% during the forecast period.

Contraception methods can be permanent or temporary that are available for both men and women. Permanent methods include tubal occlusion or hysteroscopy and vasectomy. Temporary methods are of two types, i.e., hormonal and non-hormonal, in which hormonal methods include contraceptive transdermal patches, hormonal IUDs, oral contraceptive pills, vaginal implants, and vaginal rings. Non-hormonal methods include diaphragms, withdrawal methods, sponges, condoms, non-hormonal IUDs, and cervical caps. Condoms, sponges, diaphragms, and cervical caps are also referred to as barrier contraception methods.

Awareness regarding family planning and applying the one-child policy in North American nations will boost the market. Government initiative & promotion over contraceptives to control the birth rate and avoid unwanted pregnancies are estimated to support market growth. Less cost consistent and timely use of effective contraceptives in youth is projected to favor the North American contraceptive market. 

Lack of knowledge over the use of the products is a significant factor hindering the market demand. Rising complication issues are also limiting the need of the market. Intake of particular contraceptives may cause breast cancer and other diseases, impeding the market demand. The availability of alternative products is also hampering the growth rate of the contraceptive market. 

This research report on the North American Contraceptives Market has been segmented & sub-segmented into the following categories:

By Drug Type: 

  • Contraceptive Pills
  • Topical Contraceptives
  • Contraceptive Injectable
  • Others (Contraceptive Gels, Jellies, and Creams)

By Medical Devices: 

  • Male Contraceptive Devices (Condoms)
  • Female Contraceptive Devices
    • Female Condoms
    • Intrauterine Devices
      • Hormonal IUD’s
      • Copper IUD’s
  • Contraceptive Sponges
  • Contraceptive Diaphragms
  • Subdermal Contraceptive Implants
  • Contraceptive Patches
  • Non-Surgical Permanent Contraceptive Devices

By End User: 

  • Hospitals
  • Home Care
  • Clinics
  • Ambulatory Surgical Centres

By Country: 

  • The U.S.
  • Canada
  • Rest of North America

Geographically, North America has the highest rate of male sterilization in the world, around 11.9%. Canadian institutes & NGOs arranged counseling programs to create awareness. The U.S. contraceptives market to play the leading role in the North American market. The World Health Organization says, in developing countries, 214 million women are using contraceptive pills to avoid pregnancy in the United States. It is a significant factor for the market to grow in the United States. Increasing support from government organizations is one of the factors propelling the growth rate of the market.  

The Canadian contraceptives market is leading, with prominent shares following the United States. The increasing population and growing awareness of contraceptive pills are majorly driving the demand of the market. Mexico is expected to have significant growth opportunities in the coming years with the increasing number of hospitals and pharmaceuticals.   

Some of the key players that are dominating the North America contraceptives market are Bayer HealthCare AG, Teva Pharmaceutical Industries Limited, Medisafe Distribution Inc, Pace Pharmaceuticals Inc., Medicines360, Church & Dwight, Co., Inc., Actavis, Inc., CooperSurgical, Inc., Merck & Co., Inc., Reckitt Benckiser plc, Mayer Laboratories, Inc., and Pfizer, Inc.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample